Search Records

Guidance documents for management of drugs for clinical trials involving human subjects. The sponsor must ensure that the clinical trial is conducted in accordance with the requirements of the protocol, which has been authorized by Health Canada and approved by REB(s).

COVID-19 is a new disease. A vaccine or therapy to treat or prevent this disease has not yet been developed. However, the COVID-19 pandemic has resulted in a global review of therapies that may be used to treat or prevent the disease. Canada is speeding up the importation and sale of medical...

To assist with Canada’s response to COVID-19, the Honourable Patty Hajdu, Minister of Health, announced that she has signed an Interim Order to allow expedited access to COVID-19-related medical devices for use by healthcare providers, including diagnostic test kits.

The Minister of Health, pursuant to subsection 30.1‍(1)Footnote(i) of the Food and Drugs Act Footnote(ii), makes the annexed Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19.

Overview of the Health Portfolio, issues/priorities for the first 100 days and a pocket book with Health Portfolio highlights.

COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the...

"Health Canada appreciates the critical role health professionals in Canada play in identifying, reporting and managing potential cases of COVID-19 and recognizes the pressures a surge in people requiring medical care can cause on facilities. In light of the current situation, Health Canada is...

In light of the COVID-19 outbreak, Health Canada is clarifying expectations for manufacturers, importers and market authorization holders (MAHs) regarding requirement to report adverse reactions (ARs) and medical device problems (MDPs) during a pandemic.

Deputy Minister Briefing Material – September 2019 - Overview of Health Canada as well as information on Governance and Operations.

Health Canada’s report on fees for fiscal year 2018 to 2019 is the second annual report under the Service Fees Act. This year’s report provides more detail on each fee, such as the type and rate of adjustment, the service standard and the performance result. This information provides additional...